Clinical Trial Update: Benefit of Adding Cureety TechCare Telemonitoring to Usual Care During Injectable Anticancer Treatment [NA]

View source ↗

Summary

A clinical trial evaluated adding Cureety TechCare telemonitoring to standard injectable anticancer treatment; the study at Centre Francois Baclesse has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Adult Patients Initiating Injectable Anticancer | NA | Status: COMPLETED